Literature DB >> 27454593

Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT.

Georgios Z Papadakis1, Corina Millo, Samira M Sadowski, Ulas Bagci, Nicholas J Patronas.   

Abstract

Endolymphatic sac tumors (ELSTs) are rare tumors arising from the epithelium of the endolymphatic sac and duct that can be either sporadic or associated with von Hippel-Lindau (VHL) disease. We report a case of a VHL patient with histologically proven residual ELST who underwent Ga DOTATATE PET/CT showing increased activity (SUVmax, 6.29) by the ELST. The presented case of a VHL-associated ELST with increased Ga DOTATATE uptake indicates cell-surface expression of somatostatin receptors by this tumor, suggesting the potential application of somatostatin receptor imaging using Ga DOTA-conjugated peptides in the workup and management of these patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27454593      PMCID: PMC5014707          DOI: 10.1097/RLU.0000000000001315

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  12 in total

1.  Tumors of the endolymphatic sac in von Hippel-Lindau disease.

Authors:  Russell R Lonser; H Jeffrey Kim; John A Butman; Alexander O Vortmeyer; Daniel I Choo; Edward H Oldfield
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Endolymphatic sac tumor metastatic to the spine. Case report.

Authors:  Nicholas C Bambakidis; Tina Rodrigue; Cliff A Megerian; Robert A Ratcheson
Journal:  J Neurosurg Spine       Date:  2005-07

3.  Effects of VHL deficiency on endolymphatic duct and sac.

Authors:  Sven Gläsker; Russell R Lonser; Maxine G B Tran; Barbara Ikejiri; John A Butman; Weifen Zeng; Patrick H Maxwell; Zhengping Zhuang; Edward H Oldfield; Alexander O Vortmeyer
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Spinal metastasis from endolymphatic sac tumor.

Authors:  K Y Tay; E Yu; E Kassel
Journal:  AJNR Am J Neuroradiol       Date:  2007-04       Impact factor: 3.825

5.  Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease.

Authors:  Jong-Ryool Oh; Harshad Kulkarni; Cecilia Carreras; Georg Schalch; Jung-Joon Min; Richard P Baum
Journal:  Nucl Med Mol Imaging       Date:  2012-04-27

6.  68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease.

Authors:  Valentina Ambrosini; Davide Campana; Vincenzo Allegri; Giuseppe Opocher; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

7.  Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.

Authors:  Michael S Hofman; W F Eddie Lau; Rodney J Hicks
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

Review 8.  Imaging features of von Hippel-Lindau disease.

Authors:  Rebecca S Leung; Sona V Biswas; Mark Duncan; Sheila Rankin
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

9.  Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.

Authors:  Nicholas C Bambakidis; Cliff A Megerian; Robert A Ratcheson
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

Review 10.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

View more
  3 in total

1.  Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.

Authors:  Georgios Z Papadakis; Corina Millo; Samira M Sadowski; Apostolos H Karantanas; Ulas Bagci; Nicholas J Patronas
Journal:  Clin Nucl Med       Date:  2017-03       Impact factor: 7.794

2.  The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

Authors:  Jasmine Shell; Amit Tirosh; Corina Millo; Samira M Sadowski; Yasmine Assadipour; Patience Green; Dhaval Patel; Naris Nilubol; Electron Kebebew
Journal:  Eur J Radiol       Date:  2018-11-22       Impact factor: 3.528

Review 3.  Ocular Manifestations of von Hippel-Lindau Disease.

Authors:  Misty D Ruppert; Meredith Gavin; Kelly T Mitchell; Alan N Peiris
Journal:  Cureus       Date:  2019-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.